CYSTITIS EROSIVE

This adverse event was reported 7 times

CYSTITIS EROSIVE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 BACILLUS CALMETTE-GUERIN 1 0.0006
1 INTERFERON BETA-1B 1 0.0001
2 MELPHALAN HYDROCHLORIDE 1 0.0000
3 FILGRASTIM 1 0.0000
4 GLATIRAMER ACETATE 1 0.0000
5 ETOPOSIDE 1 0.0000
6 TACROLIMUS 1 0.0000
7 CYCLOPHOSPHAMIDE FOR INJECTION 1 0.0000
8 CYCLOPHOSPHAMIDE 1 0.0000
9 INTERFERON BETA-1A 1 0.0000
See all drugs enriched for association with CYSTITIS EROSIVE

CYSTITIS EROSIVE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] 1 0.0006
1 Topoisomerase Inhibitor [EPC] 1 0.0000
2 Leukocyte Growth Factor [EPC] 1 0.0000
3 Interferon beta [EPC] 1 0.0000
4 Alkylating Drug [EPC] 1 0.0000
5 Thalidomide Analog [EPC] 1 0.0000
6 Corticosteroid [EPC] 2 0.0000
See all drug classes enriched for association with CYSTITIS EROSIVE